Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
종목 코드 TEM
회사 이름Tempus AI Inc
상장일May 30, 2025
CEOLefkofsky (Eric P)
직원 수2400
유형Ordinary Share
회계 연도 종료May 30
주소600 West Chicago Avenue
도시CHICAGO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호60654
전화18335144187
웹사이트https://investors.tempus.com/
종목 코드 TEM
상장일May 30, 2025
CEOLefkofsky (Eric P)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음